Yonezawa, H., Ikeda, A., Takahashi, R., Endo, H., Sugawara, Y., Goto, M., Kanno, M., Ogawa, S., Nakamura, K., Ujiie, H., Iwatsuki, M. Hirose, T., Sunazuka, T., Uehara, Y., Nishiya, N. Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases. iScience. 2022 Mar 7;25(3):103912. doi: 10.1016/j.isci.2022.103912.
情報薬科学分野
Harada, M., Nishi, T. Maeda, T., Tanno, K., Nishiya, N., Arima, H. How do Patients with Chronic Illnesses Respond to a Public Health Crisis? Evidence from diabetic patients in Japan during the COVID-19 pandemic. SSM Popul. Health. 2021 Dec;16:100961. doi: 10.1016/j.ssmph.2021.100961.
Nishiya, N. and Yonezawa, H., Domestication of chemicals attacking metazoan embryogenesis: Identification of safe natural products modifying developmental signaling pathways in human. J. Antibiot (Tokyo). 2021 Oct;74(10):651-659. doi: 10.1038/s41429-021-00461-y
Fukuda, T., Anzai, M., Nakahara, A., Yamashita, K., Matsukura, K., Ishibashi, F., Oku, Y., Nishiya, N., Uehara, Y., Iwao, M. Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutant. Bioorg. Med. Chem., 34: 116039 (2021)
Ujiie, H., Nihei, S., Nishiya, N., Goto, S., Asakura, Y., Miura, S., Hirai, D., Endo, M., Oyake, T., Ito, S., Chiba, T., Kudo, K.Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients. Anticancer Res. 2021 May;41(5):2591-2596. doi: 10.21873/anticanres.15038.
Nishiya, N., Oku, Y., Ishikawa, C., Fukuda, T., Dan, S., Mashima, T., Ushijima, M., Furukawa, Y., Sasaki, Y., Otsu, K., Sakyo, T., Abe, M., Yonezawa, H., Ishibashi, F., Matsuura, M., Tomida, A., Seimiya, H., Yamori, T., Iwao, M., Uehara, Y. Lamellarin 14, a Derivative of Marine Alkaloids, Inhibits the T790M/C797S Mutant Epidermal Growth Factor Receptor. Cancer Sci. 2021 May;112(5):1963-1974. doi: 10.1111/cas.14839.
西谷直之「ゼブラフィッシュ胚の表現型ダイバーシティーを利用したケミカルバイオロジー」新学術領域「細胞ダイバース」公開シンポジウム（2021年9月6日）
西谷直之「薬剤耐性肺がんに有効な新規構造を有するキナーゼ阻害薬の創製」IWATE Lung Cancer Seminar for Pharmacist（2021年7月11日）
Yonezawa, H., Sugawara, A., Sakyo, T., Uehara, Y., Kawano, T., Nishiya, N., Biochem. Biophys. Res. Commun. 532: 440-445 (2020) doi: 10.1016/j.bbrc.2020.08.031.
Nishiya, N., Murai, M., Hosoda, A., Yonezawa, H., Omori, N., Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling. Pharmaceuticals, 12 (4): 165 (2019) doi:10.3390/ph12040165